";s:4:"text";s:5530:" Previously, she served as chief operating officer and chief financial officer of Arcus Biosciences, Inc. Ms. Hemrajani also served as chief operating officer of FLX Bio (now RAPT Therapeutics). Ms. Lacy has 25 years of experience as a communicator, providing strategy, development, and execution of communications programs, both internally and externally, for publicly traded pharmaceutical and biotechnology companies. After submitting your request, you will receive an activation email to the requested email address. Investor Overview Adverum Biotechnologies Q1 2020 Conference Call ... Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Stock Quote; Stock Chart; Analyst … These are effective but typically require long-term eye injections every 4-8 weeks in order to maintain vision. Source: Adverum Biotechnologies, Inc. Dr. Osborne brings previous experience from Genentech, where he served as principal medical director in product development and global development leader for faricimab, guiding the design and execution of Phase II and Phase III studies in wet age-related macular degeneration (AMD) and diabetic macular edema (DME), respectively. Since joining Adverum in 2016, she has served as chief financial officer, and most recently as president, chief executive officer and director. in Biochemistry from the University of London, a Ph.D. in Biochemistry from the University of Cambridge, and an M.D.
In his tenure, he held leadership roles in finance, strategy, billing operations, and sales operations. He received a J.D. Ms. Patterson earned a B.S. 555-555-5555 #3456 Fax. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support We develop gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. After submitting your information, you will receive an email. Ms. Patterson currently serves on the board of directors for Nkarta, Inc.Mark Lupher, Ph.D. joined Adverum’s board in May 2019. Investor Type. Mr. Leung began his career in investment banking at Morgan Stanley. Previously, he served as chairman and chief executive officer of Tobira Therapeutics until its acquisition by Allergan in November 2016. He has served in a number of operating roles over this time, most recently as the chief operating officer of Okairos, which was sold to GlaxoSmithKline plc. The FOX-XP system is a full wafer contact and singulated die/module test and burn-in system used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. Find the latest SEC Filings data for Adverum Biotechnologies, Inc. Common Stock (ADVM) at Nasdaq.com. Mr. Kochy holds a Master of Business Administration from the University of California, Berkeley and a Bachelor of Science in Mechanical Engineering from the University of California, Los Angeles.Peter Soparkar is Adverum’s chief legal officer and joined the Company in October 2019. Compliance with this regimen can be difficult for patients, caregivers, and healthcare systems, leading to undertreatment and resulting in loss of vision.Wet AMD is a leading cause of vision loss in patients over 60 years of age, with a prevalence of approximately 1.2 million individuals in the U.S. and 3 million worldwide. in biomedical engineering and economics from Yale University, where he graduated Phi Beta Kappa and summa cum laude.Dena House is Adverum’s vice president of human resources and joined the Company in July 2019. Adverum Biotechnologies Q1 2020 Conference Call May 28, 2020 at 1:30 PM PDT 07/25/20. He currently serves as the vice president of translational pharmacology and preclinical development at Sutro Biopharma, a biotechnology company focused on clinical-stage drug discovery, development and manufacturing. Investor Relations. in Chemistry from University of California, Berkeley.Rekha Hemrajani, M.B.A. joined Adverum’s board in May 2019. Investor Overview; Stock Information.